ReviewJournal of personalized medicine2022

Homologous Recombination Deficiency (HRD) and BRCA 1/2 Gene Mutation for Predicting the Effect of Platinum-Based Neoadjuvant Chemotherapy of Early-Stage Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis.

Yue Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.